UK Turmeric Supplement Ads Outed For Using Claims 'On Hold' At EFSA
This article was originally published in The Rose Sheet
In separate rulings, ASA upholds complains that Healthspan and Cambridge Nutraceuticals made unapproved health claims for turmeric, as the firms did not provide sufficient supporting evidence and cannot rely on similar “on hold” claims on the ingredient under review by EFSA.
You may also be interested in...
Firm apologized and removed a Facebook post that promised to rid users of stubborn aches and pains after Advertising Standards Authority determined claims were unauthorized.
FTC considers Vemma settlement; UK firm's green tea claim fails; Axxess has new CEO; NeutraSci reaches Austria, Germany; and more news in brief.
Health, beauty and wellness industry stakeholders believe Lina Khan’s appointment increases chances FTC will aggressively enforce against e-commerce giant Amazon. Agency movement alleging antitrust against Amazon could impact the pricing and sales of products online.